Drug Discovery & Development | September 7, 2021
The University of Minnesota Medical School has developed a therapeutic vaccine for opioid use disorder that is the subject of a new Phase 1 randomized placebo-controlled clinical trial. Marco Pravetoni, PhD, is leading the drug discovery research and will join the UW Medicine Garvey Institute for Brain Health Solutions in 2022.
The New York Times | September 7, 2021
Caffeine has a well-justified reputation for being an energy booster, but its cumulative effect can have the opposite effect, says Mark Stein, PhD
KOMO Radio | September 4, 2021
Caleb Banta-Green, PhD, says that fentanyl brings with it a high risk of addiction and overdose and that it is flooding the market.
Psychiatric News | September 2, 2021
A telepsychiatry-based collaborative care model (CoCM) for managing patients with posttraumatic stress disorder or bipolar disorder was as effective as telepsychiatry-enhanced referral at improving patient outcomes over one year, according to a study in JAMA Psychiatry led by John Fortney, PhD.
The Seattle Times | September 2, 2021
Mental health responders are having difficultly helping people in severe crisis as police departments interpret the new policing-reform laws in different ways. House Bill 1310 was passed by the Washington Legislature this spring.
MPR News | September 1, 2021
Margaret Sibley, PhD, urges schools to make sure they serve the needs of students with ADHD in order to keep them in school and help them graduate
UW Medicine newsroom | September 1, 2021
In a paper published in Nature Neuroscience, researchers pushed the science forward on our reward pathways. Co-lead author Raajaram Gowrishankar, PhD, is a postdoctoral scholar in the Bruchas Lab and the Center for the Neurobiology of Addiction, Pain and Emotion (NAPE).
University of Washington Magazine | September 1, 2021
Washington has a shortage of mental-health workers and high demand for treatment. The UW is at the center of efforts to turn the tide. Jürgen Unützer, MD, MPH, MA, Anna Ratzliff, MD, PhD, Ryan Kimmel, MD, Mollie Forrester, MSW, LICSW, and James Lee, MD, are quoted.
UW Medicine newsroom | August 31, 2021
UW Medicine addiction researcher Caleb Banta-Green says drug manufacturers and dealers are purposefully making and selling counterfeit pills that are actually illegally made fentanyl. The synthetic opioid is 50 to 100 times more potent than morphine.
KOMO News | August 31, 2021
More people in King County have died this year from fentanyl-related accidental overdoses than any other prior year according to statistics released by Public Health – Seattle & King County. Caleb Banta-Green, PhD, says fentanyl provides its users with a quick high but wears off quickly, making it highly addictive. Also covered by KIRO Radio and Patch.
